4.7 Review

The regulatory function of piRNA/PIWI complex in cancer and other human diseases: The role of DNA methylation

期刊

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
卷 18, 期 8, 页码 3358-3373

出版社

IVYSPRING INT PUBL
DOI: 10.7150/ijbs.68221

关键词

piRNA; PIWI; DNA methylation; cancer; disease; diagnosis; therapy

资金

  1. National Natural Science Foundation of China [22006084, 81800215]
  2. Qingdao Applied Basic Research Project [19-6-2-49-cg]
  3. Hubei Key Laboratory of Environmental and Health Effects of Persistent Toxic Substances [PTS2019-05]

向作者/读者索取更多资源

This review summarizes the DNA methylation regulation mechanisms mediated by piRNA/PIWI proteins and the methylation changes caused by piRNA/PIWI proteins in different diseases, especially cancers. Dysregulation of piRNAs may contribute to disease occurrence through epigenetic changes such as DNA methylation and chromatin modification. Furthermore, piRNAs have potential clinical applications as novel biomarkers for cancer diagnosis, and the methylation changes associated with piRNA/PIWI proteins are of significant importance in treatment.
Piwi-interacting RNAs (piRNAs) are a class of short chain noncoding RNAs that are constituted by 26-30 nucleotides (nt) and can couple with PIWI protein family. piRNAs were initially described in germ line cells and are believed to be critical regulators of the maintenance of reproductive line. Increasing evidence has extended our perspectives on the biological significance of piRNAs and indicated that they could still affect somatic gene expression through DNA methylation, chromatin modification and transposon silencing, etc. Many studies have revealed that the dysregulation of piRNAs might contribute to diverse diseases through epigenetic changes represented by DNA methylation and chromatin modification. In this review, we summarized piRNA/PIWI protein-mediated DNA methylation regulation mechanisms and methylation changes caused by piRNA/PIWI proteins in different diseases, especially cancers. Since DNA methylation and inhibitory chromatin marks represented by histone H3 lysine 9 (H3K9) methylation frequently cooperate to silence genomic regions, we also included methylation in chromatin modification within this discussion. Furthermore, we discussed the potential clinical applications of piRNAs as a new type promising biomarkers for cancer diagnosis, as well as the significance of piRNA/PIWI protein-associated methylation changes in treatment, providing disparate insights into the potential applications of them.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据